Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha ...

At launch, Repatha was billed as a potential blockbuster, but insurers’ resistance to paying for the drug and a rival PCSK9 inhibitor from Sanofi/Regeneron – Praluent (alirocumab ...

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

Rosie O'Donnell said she’s lost more weight since taking Mounjaro for her diabetes, admitting that she feels healthier and her new clothing size is “shocking.” ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Rosie O’Donnell has found her recent weight loss “completely shocking”. The 62-year-old comic and actress, who suffers from ...

In the clip, the 62-year-old shared that she’s “lost more weight” since taking Mounjaro, an FDA-approved prescription medication for ... Mounjaro — and Repatha," she explained.

The 62-year-old comic and actress, who suffers from diabetes, made the admission while updating fans on her recent move to Ireland - in protest at the Donald Trump administration - and the significant ...